These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6540195)

  • 1. Hemostasis and mechanism of action of selective antimetastatic drugs in mice bearing Lewis lung carcinoma.
    Giraldi T; Sava G; Mitri E; Cherubino R
    Eur J Cancer Clin Oncol; 1984 Jul; 20(7):961-6. PubMed ID: 6540195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
    Giraldi T; Sava G; Cuman R; Nisi C; Lassiani L
    Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological analysis of metastatic potential and antimetastatic drug effects in mice bearing two lines of Lewis lung carcinoma.
    Grill V; Mallardi F; Zorzet S; Perissin L; Giraldi T
    Clin Exp Metastasis; 1987 Sep; 5(3):233-44. PubMed ID: 3652553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimetastatic action and hematological toxicity of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide used as prophylactic adjuvants to surgical tumor removal in mice bearing B16 melanoma.
    Sava G; Giraldi T; Lassiani L; Nisi C
    Cancer Res; 1984 Jan; 44(1):64-8. PubMed ID: 6690062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antimetastatic dimethyltriazenes in mice bearing Lewis lung carcinoma lines with different metastatic potential.
    Sava G; Giraldi T; Zupi G; Sacchi A
    Invasion Metastasis; 1984; 4(3):171-8. PubMed ID: 6480289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK.
    Sava G; Zorzet S; Perissin L; Pacor S; Lassiani L; Nisi C; Varnavas A
    Cancer Chemother Pharmacol; 1991; 27(6):423-8. PubMed ID: 2013112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimetastatic action of some triazene derivatives against the Lewis lung carcinoma in mice.
    Giraldi T; Houghton PJ; Taylor DM; Nisi C
    Cancer Treat Rep; 1978 May; 62(5):721-5. PubMed ID: 657157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dimethyltriazenes on in vitro Lewis lung carcinoma tumor lines with different metastatic capacity.
    Zupi G; Corsi A; Sacchi A; Lassiani L; Giraldi T
    Invasion Metastasis; 1984; 4(3):179-88. PubMed ID: 6480290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of DTIC, DM-COOK and ICRF-159 on the number of circulating Lewis lung carcinoma cells detected by flow cytometry.
    Giraldi T; Sava G; Cherubino R; Bottiroli G; Mazzini G
    Clin Exp Metastasis; 1984; 2(2):151-9. PubMed ID: 6543695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the antitumor activity of DTIC and 1-p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt on murine transplantable tumors and their hematological toxicity.
    Colombo T; D'Incalci M
    Cancer Chemother Pharmacol; 1984; 13(2):139-41. PubMed ID: 6467499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infiltration of liver and brain by tumor cells in leukemic mice: prevention by dimethyltriazenes and cyclophosphamide.
    Sava G; Giraldi T; Perissin L; Zorzet S; Mallardi F; Grill V
    Tumori; 1984 Dec; 70(6):477-83. PubMed ID: 6531789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic antimetastatic treatment with aryldimethyltriazenes as adjuvants to surgical tumor removal in mice bearing Lewis lung carcinoma.
    Sava G; Giraldi T; Nisi C; Bertoli G
    Cancer Treat Rep; 1982 Jan; 66(1):115-20. PubMed ID: 7053247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of rotational stress on the effectiveness of cyclophosphamide and razoxane in mice bearing Lewis lung carcinoma.
    Perissin L; Zorzet S; Piccini P; Rapozzi V; Giraldi T
    Clin Exp Metastasis; 1991; 9(6):541-9. PubMed ID: 1752084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimetastatic action of a new analog of dacarbazine in mice bearing Lewis lung carcinoma.
    Perissin L; Facchin P; Bedini A; Diamantini G; Tontini A; Tarzia G
    Anticancer Res; 2000; 20(3A):1513-7. PubMed ID: 10928064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of an antimetastatic agent, (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane (ICRF 159), on platelet behavior.
    Atherton A; Busfield D; Hellman K
    Cancer Res; 1975 Apr; 35(4):953-7. PubMed ID: 1116152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood coagulation changes in mice bearing Lewis lung carcinoma, a metastasizing tumor.
    Poggi A; Polentarutti N; Benedetta Donati M; de Gaetano G; Garattini S
    Cancer Res; 1977 Jan; 37(1):272-7. PubMed ID: 830414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antitumor activity of hydrosoluble analogs of p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt.
    Varnavas A; Nisi C; Lassiani L; Sava G; Perissin L; Boccù E
    Arzneimittelforschung; 1991 Nov; 41(11):1168-72. PubMed ID: 1810263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lewis lung carcinoma lines with different metastatic behavior: response to ICRF-159.
    Zupi G; Cavallari A; Greco C; Sacchi A
    Anticancer Res; 1984; 4(1-2):91-5. PubMed ID: 6712181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenic activity of the dacarbazine analog p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt in bacterial cells.
    Tamaro M; Dolzani L; Monti-Bragadin C; Sava G
    Pharmacol Res Commun; 1986 May; 18(5):491-501. PubMed ID: 3526359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of postsurgical immunotherapy with PGM in mice bearing Lewis lung carcinoma treated with p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt.
    Sava G; Zorzet S; Perissin L; Lassiani L; Tomasic J
    Methods Find Exp Clin Pharmacol; 1985 Sep; 7(9):477-80. PubMed ID: 4079598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.